From January to March 2020, purchases of pharmaceutical products made by Central American countries from companies in Mexico totaled $73 million, 2% more than reported in the same period in 2019.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with graphic"]
Agefinsa, Servicios Tecnicos Medicos, Macrotech Farmaceutica and J.I. Cohen are some of the companies that during the first quarter of the year won contracts to provide medicines and pharmaceutical products to public health institutions in the region.
The "Interactive Public Procurement Information System" of the Trade Intelligence Unit of CentralAmericaData provides interesting data on the companies that in the first quarter of 2020 were favored with contracts to provide pharmaceutical products and medical supplies to the various Ministries of Health and Social Security entities in the Central American countries.
As a result of the Coronavirus emergency, the CABEI granted each of the Central American countries financial resources for the purchase of medicines and medical supplies.
The international organization reported that it granted non-reimbursable financial cooperation in the amount of up to $8,000,000 distributed in $1,000,000 to each Central American country, including Belize, to attend to the health emergency.
The Costa Rican Social Security Fund is tendering the supply of medicinal and industrial gases at the regional level, under the delivery-on-demand modality.
Costa Rican Government Purchase 2020LN-000001-2299:
From January to September 2019, pharmaceutical product imports in Central America totaled $2.614 million, 8% more than in the same period in 2018, with El Salvador, Panama and Costa Rica being the markets where purchases increased the most.
Figures from the Trade Intelligence Unit at CentralAmericaData: [GRAFICA caption "Click to interact with graphics"]
Elvatron, Seven Pharma, J.I. Cohen, Aceti-Oxigen and Baxter are some of the companies that won contracts to provide medicines and pharmaceutical products to public health institutions in the region last year.
An analysis by the Trade Intelligence Unit of CentralAmericaData provides interesting data on the companies that were favored with contracts to provide pharmaceutical products and medical supplies to the several Ministries of Health and Social Security entities in Central American countries in 2019.
During the first semester of 2019, companies from Central American countries bought $20 million in vaccines for animal use abroad, and 55% was imported by companies in Guatemala and Costa Rica.
Figures from the Trade Intelligence Unit at CentralAmericaData: [GRAFICA caption="Click to interact with graphics"]
From January to October 2019, purchases of pharmaceutical products made by Central American countries from companies in Mexico totaled $232 million, and 63% was purchased by companies in Panama and Costa Rica.
Figures from the Trade Intelligence Unit at CentralAmericaData: [GRAFICA caption="Click to interact with graphics"]
Since Farmacias Sucre acquired most of the shares of Farmacias Santa Lucía in Costa Rica, sales of the latter have increased by 70%, mainly because of investments made in inventory.
In the first half of 2019, purchases of vaccines for human use in Central America totaled $122 million, 116% more than was reported in the same period in 2018.
Figures from the Trade Intelligence Unit at CentralAmericaData: [GRAPHIC caption="Click to interact with graphic"]
In the first six months of the year, imports of pharmaceutical products in Central America totaled $1.717 million, 8% more than in the same period in 2018.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graphic"]
The Ministry of Health decided to withdraw all registered drugs containing oral ranitidine from the market, arguing that long-term exposure of people to this substance may increase the risk of cancer.
With the available data there is no evidence that the presence of this substance could have caused harm to patients who have consumed the drug, however, the potential risk arising from the cumulative effect, makes it necessary for health regulatory authorities to take different precautionary measures to avoid their presence in medicines, informed local authorities.
In the first quarter of 2019, purchases of vaccines for human use in Central America totaled $66 million, 347% more than was reported in the same period in 2018.
Figures from the Trade Intelligence Unit at CentralAmericaData: [GRAPHIC caption="Click to interact with graphic"]
Because the country produces only 6% of the medicines demanded, there are several business opportunities that can be explored by industry businessmen.
Currently, local manufacturers do not have the capacity to produce and supply the Panamanian market, which has generated several business opportunities for several companies.
Operating Company dedicated to the manufacture of gluten-free and sugar-free products, OHNE brand. The OHNE brand has 8 product lines: square bread, sweet...
Has everything. Ocean views, waterfalls, 20 titled building sites, profits, end of the road privacy but close to everything. Less than an hour to shopping, medical services, beaches, airport. Spring and summer all year, in the 70s – 80s, fresh...
español
1916